UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medical cannabis imports allowed only through orphan drug center
by Lee Hye-seon
2019-02-22 10:55
International groups praise Korea’s dementia-combating efforts
by Lee Han-soo
2019-02-21 15:28
Korea to revise limited exclusive sales rights approval
by Lee Hye-seon
2019-02-21 11:28
Regulator to inspect 12 biopharmaceutical plants overseas
by Lee Hye-seon
2019-02-20 16:18
Government to spend ₩3 trillion on innovative drugs, dementia, medical scientists
by Kwak Sung-sun
2019-02-20 11:44
라인
Korea to raise vaccine self-sufficiency to 57% by 2020
by Lee Hye-seon
2019-02-19 14:47
Korea spreads health insurance system to Asia
by Lee Han-soo
2019-02-19 12:37
‘Innovative’ drugmakers to invest ₩1.7 trillion in developing new drugs
by Lee Han-soo
2019-02-14 11:26
WHO to revise criteria for personality disorder for 1st time in three decades
by Lee Hye-seon
2019-02-13 12:16
Direct-to-consumer genetic testing allowed for Parkinson’s, lung cancer
by Park Gi-taek
2019-02-12 14:48
라인
US pharma group asks USTR to designate Korea as priority foreign country
by Lee Han-soo
2019-02-11 17:49
Seoul goes all out to promote Korean healthcare in Middle East
by Lee Han-soo
2019-01-29 18:56
Government to tighten rule for drug license renewal
by Lee Hye-seon
2019-01-29 12:51
Korea to set up new review process for advanced medical devices
by Lee Hye-seon
2019-01-28 17:35
Government to expand insurance coverage for MRI
by Lee Han-soo
2019-01-28 17:02
라인
Two CROs reprimanded for delayed reports of adverse events
by Lee Hye-seon
2019-01-24 15:40
‘Trade deal with US makes it hard for Seoul to support local drugmakers’
by Kwak Sung-sun
2019-01-23 15:31
Court suspends FSC’s disciplinary ruling against Samsung BioLogics
by Lee Han-soo
2019-01-22 22:30
Seoul’s disease control questioned amid spreading fears over measles
by Choi Gwang-seok
2019-01-22 15:16
Top Court’s ruling affects local companies’ base-altering strategies to avoid patents
by Lee Han-soo
2019-01-18 16:36
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top